Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Life after a ventricular arrhythmia.

John Hsu1, Connie Uratsu, Alison Truman

  • 1Division of Research, Kaiser Permanente, Oakland, Calif 94611-5714, USA. jth@dor.kaiser.org

American Heart Journal
|September 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthy Days at Home after Emergency General Surgery: Shifting Towards Long-Term Patient-Centered Outcomes for Older Adults.

Journal of the American College of Surgeons·2026
Same author

Dementia and Frailty Impact Postoperative Care Trajectories and Burden among Older Adults Undergoing Radical Cystectomy for Bladder Cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Global advances in health artificial intelligence: a workforce imperative.

Lancet (London, England)·2026
Same author

Nurse and Social Worker Perceptions of Early Adoption of VA's Nationally Scaled Care Coordination Initiative.

Medical care research and review : MCRR·2026
Same author

Patient-Reported Diagnostic Excellence in Emergency Care: Cross-Site Score Variation and Purpose-Dependent Interpretation.

Joint Commission journal on quality and patient safety·2026
Same author

Epidemiology of Traumatic Brain Injury in Medicare Beneficiaries over the Last Decade: A Retrospective Observational Study.

Health science reports·2026

Outcomes after a life-threatening ventricular arrhythmia (LTVA) show initial QOL decline, followed by significant improvement with therapy. Implantable cardioverter-defibrillators (ICDs) may offer greater QOL benefits but incur higher initial costs.

Area of Science:

  • Cardiology
  • Outcomes Research
  • Health Economics

Background:

  • Limited community-based data exist on outcomes following life-threatening ventricular arrhythmias (LTVA).
  • Evaluating quality of life (QOL) and medical costs post-LTVA is crucial for patient management.

Purpose of the Study:

  • To assess QOL and medical costs in patients after their first episode of LTVA.
  • To compare outcomes between different treatment modalities for LTVA.

Main Methods:

  • Prospective evaluation of 264 patients with new-onset LTVA.
  • Utilized Duke Activity Status Index (DASI), SF-36, and CAST symptom scale for QOL assessment.
  • Tracked resource utilization and medical costs over 2 years.

Main Results:

Related Experiment Videos

  • Initial decrease in functional status post-LTVA, with significant improvement during follow-up.
  • Greater QOL and symptom improvement observed in patients treated with implantable cardioverter-defibrillators (ICDs) versus amiodarone.
  • Mental health and vitality ratings showed no significant changes between groups or over time.
  • Total 2-year medical costs were higher for ICD recipients, despite lower follow-up costs.

Conclusions:

  • New LTVA episodes significantly impact initial QOL.
  • Therapy, particularly with ICDs, can lead to QOL and symptom improvement.
  • Management of LTVA patients involves substantial healthcare costs.